More articles from Review

  • Viral hepatitis in the 1990s, part I: current principles of management
    William D. Carey, MD and Girish Patel, MD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 317-325;

    An update of the clinical management of viral hepatitis, based on recent developments in screening and diagnosis.

  • Pharmacotherapy of multiple sclerosis: current status
    Richard A. Rudick, MD, Donald E. Goodkin, MD and Richard M. Ransohoff, MD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 267-277;

    With careful drug selection and close monitoring, many symptoms associated with MS are effectively controlled.

  • Doppler echocardiographic assessment of constrictive pericarditis, cardiac amyloidosis, and cardiac tamponade
    Allan L. Klein, MD and Gerald I. Cohen, MD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 278-290;

    Doppler echocardiography is emerging as an excellent noninvasive way to assess diastolic function, and its array of clinical applications is expanding.

  • Lung and heart-lung transplantation: the state of the art
    Patrick M. McCarthy, MD, Thomas J. Kirby, MD, Richard D. White, MD, Thomas W. Rice, MD, Eliot R. Rosenkranz, MD, Andrea P. Baldyga, MD, Rita Vargo, RN and Atul C. Mehta, MD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 307-316;

    Lung and heart-lung transplantation is no longer experimental, but a reasonable option in many heart and lung disorders previously deemed fatal.

  • Indications for electrophysiologic study in patients with ventricular arrhythmias
    Sergio L. Pinski, MD and James D. Maloney, MD
    Cleveland Clinic Journal of Medicine March 1992, 59 (2) 175-185;

    An analysis of current guidelines for the use of electrophysiologic study, and a look at practical applications.

  • Sleep in the patient with lung disease
    David P. Meeker, MD
    Cleveland Clinic Journal of Medicine March 1992, 59 (2) 157-165;

    How to recognize and manage the ill effects that sleep-related respiratory changes can have on underlying lung disease, including COPD, asthma, and interstitial lung disease.

  • Survivors of sudden cardiac death: a rational approach to evaluation and therapy of patients surviving ventricular fibrillation
    Arthur J. Rabinowitz, MD and James D. Maloney, MD
    Cleveland Clinic Journal of Medicine March 1992, 59 (2) 166-172;

    A strategy for identifying underlying disease, stratifying the risk of recurrence, and formulating specific therapy in these patients, at high risk for life-threatening ventricular tachyarrhythmias.

  • The phenomenal growth of laparoscopic cholecystectomy: a review
    Raphael S. Chung, MD and Thomas A. Broughan, MD
    Cleveland Clinic Journal of Medicine March 1992, 59 (2) 186-190;

    Touted by surgeons who perforin it and demanded by a public attracted by claims of reduced pain and fast recovery, laparoscopic cholecystectomy is taking the United States by storm. The authors provide insight into the appropriate use of this operation.

  • Experimental therapies for multiple sclerosis: current status
    Donald E. Goodkin, MD, Richard M. Ransohoff, MD and Richard A. Rudick, MD
    Cleveland Clinic Journal of Medicine January 1992, 59 (1) 63-74;

    A critical analysis of current experimental agents and obstacles to the development of effective drug therapy.

  • Experimental limbic epilepsy: models, pathophysiologic concepts, and clinical relevance
    Mohamed Nayel, MD, Issam A. Awad, MD, Mark Larkins, MD and Hans Lüders, MD, PhD
    Cleveland Clinic Journal of Medicine November 1991, 58 (6) 521-530;

    Complex partial seizures originating in the temporal lobe are common in epilepsy patients. Drug treatment is often ineffective. What predisposes a patient to these seizures? How do they occur? Animal studies are providing clues to the puzzle.

Pages